Position in SVRA
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$12,423,580
New position
Shares Held
2,275,381
first reported quarter
Ownership
1.11%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 184 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 90.97083081910239.ToString("F0")%
Shared 0.ToString("F0")%
None 9.029169180897616.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pictet Asset Management Holding SA holds $3,316,428,809 across 130 Biotechnology names. SVRA ranks #58 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
337,254 | $260,575,930 | |
| 2 | INSM |
INSMED Inc
|
1,102,248 | $180,239,592 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
337,569 | $150,738,061 | |
| 4 | ARGX |
Argenx SE
|
148,306 | $108,300,456 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,434,995 | $107,753,774 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
1,381,184 | $102,566,723 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
187,240 | $98,014,522 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
286,644 | $92,353,830 |
All Filings in SVRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,423,580 | 2,275,381 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||